UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Drug research: myths, hype and reality

Nature reviews. Drug discovery, 2003-08, Vol.2 (8), p.665-668

Kubinyi, Hugo

2003

Volltextzugriff (PDF)

QSAR and 3D QSAR in drug design Part 1: methodology

Drug discovery today, 1997-11, Vol.2 (11), p.457-467

Kubinyi, Hugo

1997

Volltextzugriff (PDF)

QSAR and 3D QSAR in drug design Part 2: applications and problems

Drug discovery today, 1997-12, Vol.2 (12), p.538-546

Kubinyi, Hugo

1997

Volltextzugriff (PDF)

Strategies and recent technologies in drug discovery

Pharmazie, 1995-10, Vol.50 (10), p.647-662

KUBINYI, H

1995

Volltextzugriff (PDF)

A Scoring Scheme for Discriminating between Drugs and Nondrugs

Journal of medicinal chemistry, 1998-08, Vol.41 (18), p.3325-3329

1998

Volltextzugriff (PDF)

Evolutionary variable selection in regression and PLS analyses

Journal of chemometrics, 1996-03, Vol.10 (2), p.119-133

Kubinyi, Hugo

1996

Volltextzugriff (PDF)

Chemical similarity and biological activities

Journal of the Brazilian Chemical Society, 2002-11, Vol.13 (6), p.717-726

Kubinyi, Hugo

2002

Volltextzugriff (PDF)

Chance Favors the Prepared Mind - From Serendipity to Rational Drug Design

Journal of receptors and signal transduction, 1999, Vol.19 (1-4), p.15-39

Kubinyi, Hugo

1999

Volltextzugriff (PDF)

Chemogenomics in drug discovery

Ernst Schering Research Foundation workshop, 2006 (58), p.1

Kubinyi, H

2006

Volltextzugriff (PDF)

New Trends in Synthetic Medicinal Chemistry

1, 2008

Volltextzugriff (PDF)

Three-Dimensional Quantitative Similarity−Activity Relationships (3D QSiAR) from SEAL Similarity Matrices

Journal of medicinal chemistry, 1998-07, Vol.41 (14), p.2553-2564

1998

Volltextzugriff (PDF)

Glossary of terms used in computational drug design (IUPAC Recommendations 1997)

Pure and applied chemistry, 1997-05, Vol.69 (5), p.1137-1152

1997

Volltextzugriff (PDF)

The design of combinatorial libraries

Drug discovery today, 2002-05, Vol.7 (9), p.503-504

Kubinyi, Hugo

2002

Volltextzugriff (PDF)

Virtual Discovery Europe--Select Biosciences Conference. Computer-aided drug design and screening

IDrugs : the investigational drugs journal, 2007-12, Vol.10 (12), p.869

Kubinyi, Hugo

2007

Volltextzugriff (PDF)

The Evolution of Drugs

Medicinal chemistry research, 2004-01, Vol.13 (1-2), p.5-6

Kubinyi, Hugo

2004

Volltextzugriff (PDF)

3.40 - Chemogenomics

Comprehensive Medicinal Chemistry II, 2007, Vol.3, p.921-937

Kubinyi, H.

Second Edition, 2007

Volltextzugriff (PDF)

Lipophilicity and drug activity

Progress in drug research, 1979, Vol.23, p.97

Kubinyi, H

1979

Volltextzugriff (PDF)

Bioinformatics--from genomes to drugs

Lengauer, T. (Thomas)

2002

Volltextzugriff (PDF)

Spectrophotometric analysis of multicomponent systems: the law and the error

TrAC, Trends in analytical chemistry (Regular ed.), 1995-05, Vol.14 (5), p.199-201

Kubinyi, Hugo

1995

Volltextzugriff (PDF)

From Narcosis to Hyperspace: The History of QSAR

Quantitative structure-activity relationships, 2002-10, Vol.21 (4), p.348-356

Kubinyi, Hugo

2002

Volltextzugriff (PDF)

Quantitative structure-activity relationships (QSAR) and molecular modelling in cancer research

Journal of cancer research and clinical oncology, 1990-01, Vol.116 (6), p.529-537

KUBINYI, H

1990

Volltextzugriff (PDF)

Quantitative structure-activity relationships. IV. Non-linear dependence of biological activity on hydrophobic character: a new model

Arzneimittel-Forschung, 1976, Vol.26 (11), p.1991

Kubinyi, H

1976

Volltextzugriff (PDF)

Similarity and dissimilarity : A medicinal chemist's view: 3D QSAR in drug design: ligand-protein interactions and molecular similarity

Perspectives in drug discovery and design, 1998, Vol.9-11, p.225-252

KUBINYI, H

1998

Volltextzugriff (PDF)

Quantitative structure--activity relationships. 7. The bilinear model, a new model for nonlinear dependence of biological activity on hydrophobic character

Journal of medicinal chemistry, 1977-05, Vol.20 (5), p.625-629

Kubinyi, H

1977

Volltextzugriff (PDF)

Molecular similarity. 2. The structural basis of drug design

Pharmazie in unserer Zeit, 1998-07, Vol.27 (4), p.158-172

Kubinyi, H

1998

Volltextzugriff (PDF)

1 – 25 von 106

Menü

Weitere Dienste

Einstellungen

Drug research: myths, hype and reality

QSAR and 3D QSAR in drug design Part 1: methodology

QSAR and 3D QSAR in drug design Part 2: applications and problems

Strategies and recent technologies in drug discovery

A Scoring Scheme for Discriminating between Drugs and Nondrugs

Evolutionary variable selection in regression and PLS analyses

Chemical similarity and biological activities

Chance Favors the Prepared Mind - From Serendipity to Rational Drug Design

Chemogenomics in drug discovery

New Trends in Synthetic Medicinal Chemistry

Three-Dimensional Quantitative Similarity−Activity Relationships (3D QSiAR) from SEAL Similarity Matrices

Glossary of terms used in computational drug design (IUPAC Recommendations 1997)

The design of combinatorial libraries

Virtual Discovery Europe--Select Biosciences Conference. Computer-aided drug design and screening

The Evolution of Drugs

3.40 - Chemogenomics

Lipophilicity and drug activity

Bioinformatics--from genomes to drugs

Spectrophotometric analysis of multicomponent systems: the law and the error

From Narcosis to Hyperspace: The History of QSAR

Quantitative structure-activity relationships (QSAR) and molecular modelling in cancer research

Quantitative structure-activity relationships. IV. Non-linear dependence of biological activity on hydrophobic character: a new model

Similarity and dissimilarity : A medicinal chemist's view: 3D QSAR in drug design: ligand-protein interactions and molecular similarity

Quantitative structure--activity relationships. 7. The bilinear model, a new model for nonlinear dependence of biological activity on hydrophobic character

Molecular similarity. 2. The structural basis of drug design

Suchergebnisse filtern